James K Stokes, M.D. Internal Medicine - Nephrology Medicare: Not Enrolled in Medicare Practice Location: 115 Overland Dr, Greenwood, SC 29646 Phone: 864-227-6641 Fax: 864-227-3953 |
Allan P Turner, M.D. Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 115 Overland Drive, Greenwood, SC 29646 Phone: 864-227-6641 Fax: 864-227-3953 |
Dr. Christine Adefuin Murakami, M.D. Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1123 Spring St, Greenwood, SC 29646 Phone: 864-450-9036 |
News Archive
Astex Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration has issued a Complete Response Letter to partner Eisai for their supplemental New Drug Application (sNDA) for Dacogen (decitabine) for Injection for patients with acute myeloid leukemia (AML) in adults 65 years of age or older who are not considered candidates for induction therapy.
A new Phase I clinical trial conducted at Cedars-Sinai Medical Center's Maxine Dunitz Neurosurgical Institute in Los Angeles shows that two innovative treatment approaches may safely be combined to treat patients with highly aggressive, malignant brain tumors called gliomas. The results suggest that combining the two therapies might boost their effectiveness and supports the pursuit of additional studies on this approach to treating these tumors.
Ben-Gurion University of the Negev and the PTT Chemical Public Company Ltd. in Thailand have signed a research and development collaboration agreement for commercial development of BGU's proprietary green algae strain.
A particular human gene variant makes breast cancer cells more aggressive. Not only are these more resistant to chemotherapy but also leave the primary tumour and establish themselves in other parts of the body in the form of metastases. An international group of researchers led by Lukas Kenner of MedUni Vienna has now identified a gene, AF1q, as being substantially responsible for this and recognized it as a possible starting point for more accurate diagnosis and potential targeted therapeutic approaches.
A biopharmaceutical company collaborating with Hawai'i scientists on an Ebola vaccine announced encouraging news about its vaccine today.
› Verified 9 days ago